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Abstract 
Bipolar disorders (BDs) are prevalent, comorbid and disabling conditions, associated with the 
highest suicide risk among psychiatric illnesses. In the last few years, new efforts to better 
characterize the socio-demographic and clinical profiles of BD type I vs II have been documented 
by several reports, with novel and insightful findings in the field. The present multicenter study 
aimed to provide a comprehensive and reliable representation of the Italian reality, through the 
analysis of the largest national sample of bipolar patients collected so far. A total of 1500 patients 
(BD I n = 963 and BD II n = 537) from different psychiatric departments, participating in the Italian 
Chapter of the “International Society of Bipolar Disorders” (ISBD), were assessed and divided into 
two groups on the basis of their diagnostic subtype, and different socio-demographic and clinical 
variables were compared between the two subgroups. Chi-squared tests for categorical variables 
and t tests for continuous variables were performed for group comparison. Furthermore, a 
multivariable logistic regression was performed, considering diagnostic bipolar subtype (type I or 
II) as dependent variable, and socio-demographic/clinical characteristics as independent variables. 
BD I vs II patients showed an overall less favorable socio-demographic and clinical profile. In 
addition, the multivariable logistic regression showed that BD II vs BD I was predicted by the 
absence of lifetime suicide attempts (OR = 1.58, p = 0.01), a later age of diagnosis 
(OR = 1.03, p < 0.01), less hypomanic episodes in the last year (OR = 2.29, p < 0.0001) and absence 
of psycho-educational interventions in the last year (OR = 0.51, p < 0.01). BD I and II patients were 
found to significantly differ in relation to specific clinical variables, which should be considered 
within updated diagnostic–therapeutic algorithms. 
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Introduction 
Bipolar disorders type I (BD I) and II (BD II) represent the main defined conditions within the 
chapter of bipolar disorders by the DSM-5 [1] and are characterized by variable prevalence, socio-
demographic and clinical features [2, 3]. In alternative to the DSM classification, BD can be seen as 
a diagnostic entity included within the Mood Spectrum Disorders, which are characterized by 
alternation of mood episodes of different severity [4]. In addition a number of authors claim the 
revision of manic/hypomania criteria to have more reliable figures of prevalence of BD in the 
general population [5]. A shortening of duration of hypomania and mania as a criterion for a 
diagnosis of BD has demonstrated its validity to discriminate bipolar patients from unipolar subjects 
[6]. In addition, similar social dysfunction (increased in health service utilization, need for welfare 
and suicidal behavior) was found between subsyndromal manic patients and manic/hypomania 
subjects with respect to healthy individuals [7]. Recent investigation showed that the two bipolar 
subtypes may not be better conceived as a more and less severe variant of the same illness but, more 
likely, as subgroups of disorders with peculiar longitudinal expressions of illness severity, 
including, for instance, lifetime number of mood episodes, suicide risk, and treatment response. In 
this perspective, in fact, BD II compared to BD I patients can in multiple ways be more severe, as 
evidenced by more common associations with unfavorable illness characteristics [8], including 
more depressive [9, 10, 11] and overall episodes [12], and higher rates of anxiety disorder 
comorbidity [13, 14], rapid cycling course [15, 16], and family history of mood disorders [9, 17]. In 
addition, patients suffering from BD II vs I have shown greater risk of suicide attempt in some 
[18, 19, 20] but not all studies [21, 22, 23]. On the other hand, most studies in the field have found 
that BD I vs II patients show more severe characteristics of illness, as evidenced by more common 
associations with prior psychosis [24], psychiatric hospitalization [24, 25] and overall less favorable 
socio-demographic status and global functioning [26]. 
Ultimately, the presence of specific clinical features, including childhood onset [27], lifetime 
presence of psychotic symptoms [28] and the presence of certain comorbidity patterns [29], 
associated with the different subtypes of BD, may confer a higher severity of illness to BD I and II 
patients. 
Factors that can contribute to a higher severity of illness, within specific subgroups of BD I and II 
patients, may be, moreover, represented by the setting, with more severe cases—particularly 
amongst BD II subjects [8]—potentially attending tertiary clinics and not necessary reflecting the 
characteristics of patients followed elsewhere. 
Overall, the available data about the clinical severity of the two main BD subtypes are partly 
contradictory and for this reason the purpose of the present paper is to compare socio-demographic 
and clinical features between BD subtypes in a large Italian multicenter sample. This can clarify the 
terms in which one of the two forms of BD may be more severe than the other. For example, a 
greater association of one of the two forms with suicide attempts could drive the clinicians towards 
targeted treatments [30]. Conversely an earlier age at onset of BD I vs BD II could orient preventive 
measures to certain age groups in the general population [31]. 
Methods 
An overall sample of 1609 patients was intially enrolled from different Italian psychiatric clinics. 
The sample was intended to be representative of the entire national territory. The protocol was 
approved by the local Ethical Committees. Patients had a diagnosis of BD (type I or type II) 
according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria [32]. 
Mood episodes, including hypomania, were also defined according to DSM criteria. Diagnoses 
were made by expert psychiatrists, who had regularly followed up the selected patients and 
confirmed by the MINI International Neuropsychiatric Interview [33]. Patients consecutively 
presenting to outpatient or inpatient services were included in the study. Clinical information was 
gathered through a review of the clinical charts and clinical interviews with patients and available 
relatives. Data were entered into an electronic central database (electronic Case Report Form: e-
CRF). Collected data included the following socio-demographic and clinical variables divided into 
three clusters: 
 cluster 1 (socio-demographic variables): age, gender, education (years), employment, 
marital status (at least 1 marriage or partnership), living alone; 
 cluster 2 (lifetime clinical variables): age at onset of BD, age at first pharmacological 
prescription (including benzodiazepines), age at first contact with psychiatric services, first 
psychiatric diagnosis, age at first diagnosis of BD, age at first mood stabilizer/atypical 
antipsychotic, polarity of first episode, number of manic/hypomanic episodes, lifetime 
number of depressive episodes, duration of untreated illness, prevalent polarity, prevalent 
course, lifetime psychotic symptoms, lifetime attempted suicide; 
 cluster 3 (clinical variables-last year of observation): presence of hypomanic episodes, 
psychotic symptoms, hospitalizations, presence of insight, attribution of symptoms to a 
psychiatric disorder, treatment adherence, psychoeducational interventions (according to 
Colom’s model) [34], acceptability of treatment by patients. 
Prevalent polarity was calculated according to the definition provided by the Barcelona Bipolar 
Disorder Group [35]. Manic prevalent polarity is characterized by at least two-thirds of past 
episodes complying with DSM-IV criteria for manic/hypomanic episodes, while depressive 
prevalent polarity is defined as at least two-thirds of a patient’s past episodes fulfilling DSM-IV 
criteria for a major depressive episode [35]. 
Exclusion criteria were the following: (1) patients who had not been examined in the last 12 months 
for the impossibility to collect data of cluster 3 variables (last year of observation); (2) patients 
whose the information about the bipolar type diagnosis was not available; (3) patients with a 
diagnosis of dementia, mental retardation or other medical conditions (e.g., untreated endocrine 
disorders) associated with an increased risk of psychotic symptoms. 
Descriptive analyses of the total sample were performed. The subgroups (divided according to the 
diagnostic subtype) were compared by Student’s t tests for quantitative variables and Chi-square 
tests for qualitative ones. Owing to the large number of variables statistically related to the 
dependent variable (bipolar subtype) at the univariate analyses, preliminary multiple logistic 
regression analyses (one for each above-mentioned cluster) were performed including only 
statistically significant variables. Finally, statistically significant variables from these final models 
were then inserted in a new starting multivariable logistic regression model to obtain the variables 
independently associated with the outcome. 
The selection of the variables has been done according to a backward procedure; in the last 
multivariable logistic model, the gender and the age (not statistically significant) have been kept 
into the model to obtain the estimates adjusted for these two variables. The goodness of fitting has 
been assessed by the Hosmer–Lemeshow test. 
The level of statistical significance was set at p < 0.05. Statistical analyses have been performed by 
SAS® 9.2 version. 
Results 
The sample included 1500 patients: 648 males (43.2%) and 852 females (56.8%). Patients 
had an age between 18 and 80 (mean: 48.61 ± 13.43). Nine hundred and sixty-three 
patients were affected by BD I (64.2%) and 537 by BD II (35.8%). One hundred and nine 
patients have been excluded from the analysis as a result of missing data about bipolar 
type diagnosis. Twenty-seven centers scattered throughout the Italian territory contributed 
to the final sample: 8 centers (29.6%) enrolled about 100 patients each, 7 centers (26.0%) 
enrolled about 50–80 patients each, and 12 centers (44.4%) enrolled about 10–50 patients 
each. 
Descriptive analyses of the total sample and of the two groups, divided according to 
bipolar subtype, are reported in Tables 1, 2 and 3. Of note, age at first pharmacological 
prescription is earlier than age at onset of BD: this is probably due to psychiatric 
comorbidity (e.g. with anxiety disorders with onset before BD) or alternatively delayed 
diagnosis. 
Patients divided according to diagnostic subtype were not different in terms of years of 
education (χ2 = 2.49, df = 2, p = 0.28). 
In contrast, BD II patients were found to be more frequently females 
(χ2 = 5.21, df = 1, p = 0.02), older (t = −4.98, p < 0.0001), employed 
(χ2 = 7.20, df = 1, p < 0.01), at least married once or partnered (χ2 = 11.56, df = 1, p < 0.001) 
and to live with someone (χ2 = 3.8, df = 1, p = 0.05). In addition, BD II vs I patients 
showed a later age at onset (t = −6.21, p < 0.0001), age at first psychiatric diagnosis 
(t = −6.12, p < 0.0001), age at first pharmacological prescription (including 
benzodiazepines) (t = −6.13, p < 0.0001), age at first contact with psychiatric services 
(t = −7.07, p < 0.0001), age at first diagnosis of BD (t = −11.11, p < 0.0001), and age at 
first Mood Stabilizer/Atypical Antipsychotic (t = −10.91, p < 0.0001). BD II vs I 
individuals had also a more frequent misdiagnosis with major depressive disorder (MDD) 
(χ2 = 43.97, df = 2, p < 0.0001), depressive polarity of first episode 
(χ2 = 101.4, df = 2, p < 0.0001), depressive prevalent polarity 
(χ2 = 147.7, df = 2, p < 0.0001), prevalent course depression/hypomania 
(χ2 = 14.44, df = 2, p = 0.0007), absence of lifetime psychotic symptoms 
(χ2 = 245.81, df = 1, p < 0.0001), absence of lifetime suicide attempts 
(χ2 = 10.7, df = 1, p = 0.001), a longer duration of untreated illness (>2 years) 
(χ2 = 29.36, df = 1, p < 0.0001), a higher number of depressive episodes 
(χ2 = 43.55, df = 3, p < 0.0001) and a lower number of hypomanic/manic episodes 
(χ2 = 538.68, df = 3, p < 0.0001). Finally, in the last year of observation, BD II vs I subjects 
showed more frequently the presence of insight (χ2 = 27.52, df = 2, p < 0.0001), attribution 
of symptoms to a psychiatric disorder (χ2 = 22.06, df = 2, p < 0.0001), treatment adherence 
(χ2 = 62.08, df = 2, p < 0.0001) and probability of satisfaction with antidepressant treatment 
(χ2 = 29.88, df = 2, p < 0.0001). On the other hand, BD II vs I patients showed less 
frequently the presence of hypomanic episodes (χ2 = 50.40, df = 1, p < 0.0001), 
psychoeducational interventions (χ2 = 7.36, df = 2, p = 0.025), psychotic symptoms 
(χ2 = 85.67, df = 1, p < 0.0001) and hospitalizations (χ2 = 24.25, df = 1, p < 0.0001). No 
differences were found in terms of major depressive episodes in the last year of 
observation between BD I and II patients (p = 0.23). 
The goodness-of-fit test results (Hosmer and Lemeshow Test: χ2 = 13.33, df = 8, p = 0.1) 
showed that multivariable logistic regression model including socio-demographic/clinical 
variables as possible predictors of BD II subtype was adequate. In particular, the absence 
of lifetime attempted suicides (OR = 1.58, p = 0.01) (Fig. 1), a later age of BD diagnosis 
(OR = 1.03, p < 0.01) (Fig. 2), less hypomanic episodes in the last year 
(OR = 2.29, p < 0.0001) and absence of psychoeducational interventions in the last year 
(OR = 0.51, p < 0.01) were all found to be predictors of BD II (Table 4). 
 
 
 Discussion 
To date and to authors’ knowledge, the present study is the first national report conducted 
on the largest Italian sample of bipolar patients, assessing related differences in terms of 
socio-demographic and clinical variables. 
The main results of this study (as shown by binary logistic regression) indicate that BD II 
patients have fewer lifetime suicide attempts, a later psychiatric diagnosis and are treated 
less frequently with psycho-educational interventions than BD I patients. In addition, BD I 
patients were found to have more hypomanic episodes in the last year than BD II patients, 
similarly to what has been reported in previous researches [36], although without 
statistical significance. Of note, in the paper by Kupka and collaborators [36], the lack of 
statistical significance might have been due to the distinct sample size, type of patients 
(only outpatients vs outpatients plus inpatients), distinct way of assessing hypomania 
(time spent in this state vs number of hypomanic episodes). 
With regard to attempted suicides, available data are contrasting with regard to a 
difference in suicide attempts between BD I and II. Some researches did not find 
significant differences according to bipolar subtype [7; 21]; others found a higher 
frequency of suicide attempts in bipolar 2 patients [18] as a result of more probable mixed 
depressed episodes [37], while further researches found a higher frequency of suicide 
attempts in bipolar 1 subjects than in bipolar 2 ones [38]. Severity of depression and 
dysphoric-agitated mixed phases of illness have been indicated as strong predictors of 
suicidal behavior in BD [39]. Some studies reported more severe depressive episodes such 
as the psychotic ones [40] and more frequent mixed depression in bipolar 1 patients [41] 
thus supporting the findings of the present research. However, our results may be biased 
by other factors such as different distribution of ethnicity [42] and female gender in the 
two groups of patients as well as distinct duration of illness, all variables that are 
considered to be associated with increased suicidal behavior in BD [43, 44, 45]. However, 
our sample was almost exclusively composed by Caucasians, the two sub-groups of 
patients had a similar duration of illness (17.6 years in BD I subjects and 17.22 years in 
BD II subjects) and BD II group showed a greater representation of females. Despite these 
observations, other factors could be influenced the result of a higher risk of suicide 
attempts in bipolar 1 vs bipolar 2 patients, such as the inclusion of inpatients [29] and 
bipolar subjects with a severe clinical presentation (e.g. with psychotic symptoms 
associated with increased suicide risk) [46, 47]. Of note, reasons for hospitalization 
include high suicidal risk and in our sample bipolar 1 subjects presented more 
hospitalizations in the last year with respect to bipolar 2 patients. This means that bipolar 
inpatients might be more represented by BD I subjects who have a high suicidal risk [48]. 
With regard to the delayed diagnosis in BD II patients, several studies in the literature 
confirm this finding [49]. A delayed diagnosis of this subtype of bipolar patients may be 
due to a lower recognition by patients and their relatives of hypomanic episodes with a 
delay in access to psychiatric services [50], or alternatively to a misdiagnosis with 
recurrent MDD [51] or substance misuse disorders by clinicians [52]. Of note, the 
consequences of a delayed diagnosis or a misdiagnosis of these patients may lead to an 
improper treatment (e.g. antidepressant mono-therapy) and to a worse outcome consisting 
of more relapses [53] and more suicidal attempts [54]. In addition, improper prolonged 
antidepressant mono-therapy may explain high frequency of dysphoric-agitated depression 
[55] and suicide attempts in bipolar 2 patients [21]. 
Purposes of psychoeducation include the improvement of illness insight and treatment 
adherence, early symptom identification and development of coping strategies [56]. The 
finding of a higher frequency of psychoeducation in BD I patients is not surprising 
because available data indicate poorer insight and less treatment adherence in BD type 1 
than in type 2 (also as a consequence of manic episodes and more frequent psychotic 
symptoms) [57, 58, 59, 60]. In addition, a recent systematic review reported that 
psychoeducation seems to be more effective for prevention of manic/hypomanic episodes 
than for depressive ones, perhaps representing an intervention more targeted for bipolar 1 
than bipolar 2 subjects [61]. 
Limitations 
The following limitations of the present research need to be taken into account:  
1. 1. 
patients were treated with different drugs which might have influenced reported 
results; 
  
2. 2. 
the different settings of care (in several Italian regions) may have influenced the 
clinical and demographic characteristics of the sample; 
  
3. 3. 
some data were collected retrospectively (e.g. duration of untreated illness or number 
of mood episodes) so that they might have not been always as accurate as in 
controlled studies; 
  
4. 4. 
the heterogeneity of number of subjects in the two sub-groups of patients as a 
consequence of the naturalistic and retrospective design of the study. 
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